298 related articles for article (PubMed ID: 27766264)
1. ABC Transporter Subfamily D: Distinct Differences in Behavior between ABCD1-3 and ABCD4 in Subcellular Localization, Function, and Human Disease.
Kawaguchi K; Morita M
Biomed Res Int; 2016; 2016():6786245. PubMed ID: 27766264
[TBL] [Abstract][Full Text] [Related]
2. ABC subfamily D proteins and very long chain fatty acid metabolism as novel targets in adrenoleukodystrophy.
Morita M; Shimozawa N; Kashiwayama Y; Suzuki Y; Imanaka T
Curr Drug Targets; 2011 May; 12(5):694-706. PubMed ID: 21039332
[TBL] [Abstract][Full Text] [Related]
3. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
4. Substrate Specificity and the Direction of Transport in the ABC Transporters ABCD1-3 and ABCD4.
Kawaguchi K; Imanaka T
Chem Pharm Bull (Tokyo); 2022; 70(8):533-539. PubMed ID: 35908918
[TBL] [Abstract][Full Text] [Related]
5. Peroxisomal ABC transporters: structure, function and role in disease.
Morita M; Imanaka T
Biochim Biophys Acta; 2012 Sep; 1822(9):1387-96. PubMed ID: 22366764
[TBL] [Abstract][Full Text] [Related]
6. Role of family D ATP-binding cassette transporters (ABCD) in cancer.
Hlaváč V; Souček P
Biochem Soc Trans; 2015 Oct; 43(5):937-42. PubMed ID: 26517907
[TBL] [Abstract][Full Text] [Related]
7. A role for the human peroxisomal half-transporter ABCD3 in the oxidation of dicarboxylic acids.
van Roermund CW; Ijlst L; Wagemans T; Wanders RJ; Waterham HR
Biochim Biophys Acta; 2014 Apr; 1841(4):563-8. PubMed ID: 24333844
[TBL] [Abstract][Full Text] [Related]
8. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
Baarine M; Beeson C; Singh A; Singh I
J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
[TBL] [Abstract][Full Text] [Related]
9. Differential substrate specificities of human ABCD1 and ABCD2 in peroxisomal fatty acid β-oxidation.
van Roermund CW; Visser WF; Ijlst L; Waterham HR; Wanders RJ
Biochim Biophys Acta; 2011 Mar; 1811(3):148-52. PubMed ID: 21145416
[TBL] [Abstract][Full Text] [Related]
10. The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters.
van Roermund CW; Visser WF; Ijlst L; van Cruchten A; Boek M; Kulik W; Waterham HR; Wanders RJ
FASEB J; 2008 Dec; 22(12):4201-8. PubMed ID: 18757502
[TBL] [Abstract][Full Text] [Related]
11. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
12. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
[TBL] [Abstract][Full Text] [Related]
13. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism, ABC half-transporters and the complicated route to treatment.
Kemp S; Wanders RJ
Mol Genet Metab; 2007 Mar; 90(3):268-76. PubMed ID: 17092750
[TBL] [Abstract][Full Text] [Related]
14. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
15. Peroxisomal ABC Transporters: An Update.
Tawbeh A; Gondcaille C; Trompier D; Savary S
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34198763
[TBL] [Abstract][Full Text] [Related]
16. Effect of dietary polyunsaturated fatty acids on the expression of peroxisomal ABC transporters.
Leclercq S; Skrzypski J; Courvoisier A; Gondcaille C; Bonnetain F; André A; Chardigny JM; Bellenger S; Bellenger J; Narce M; Savary S
Biochimie; 2008 Oct; 90(10):1602-7. PubMed ID: 18585430
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol regulates ABCD2 expression: implications for the therapy of X-linked adrenoleukodystrophy.
Weinhofer I; Forss-Petter S; Zigman M; Berger J
Hum Mol Genet; 2002 Oct; 11(22):2701-8. PubMed ID: 12374760
[TBL] [Abstract][Full Text] [Related]
18. A Thyroid Hormone-Based Strategy for Correcting the Biochemical Abnormality in X-Linked Adrenoleukodystrophy.
Hartley MD; Kirkemo LL; Banerji T; Scanlan TS
Endocrinology; 2017 May; 158(5):1328-1338. PubMed ID: 28200172
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity overlap and interaction between adrenoleukodystrophy protein (ALDP/ABCD1) and adrenoleukodystrophy-related protein (ALDRP/ABCD2).
Genin EC; Geillon F; Gondcaille C; Athias A; Gambert P; Trompier D; Savary S
J Biol Chem; 2011 Mar; 286(10):8075-8084. PubMed ID: 21209459
[TBL] [Abstract][Full Text] [Related]
20. Metformin-induced mitochondrial function and ABCD2 up-regulation in X-linked adrenoleukodystrophy involves AMP-activated protein kinase.
Singh J; Olle B; Suhail H; Felicella MM; Giri S
J Neurochem; 2016 Jul; 138(1):86-100. PubMed ID: 26849413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
